The tricuspid valve includes the annulus, leaflets, chordae tendineae, and papillary muscles. The tricuspid valve annulus is the attachment edge of the valve leaflets. The tricuspid valve has three leaflets, namely the anterior valve, the posterior valve and the septal valve. Compared with the mitral valve, the tricuspid valve has a larger opening, thinner leaflets, and more transparency. The anterior papillary muscle sends out chordae tendineae to connect with the anterior and posterior flaps, and the posterior papillary muscle sends out chordae tendineae to connect with the posterior and septal flaps. The septal papillary muscle has chordae tendineae attached to the anterior and septal flaps. The normal function of the tricuspid valve depends on the The integrity and coordination of these structural components.
Tricuspid Valve Interventional Therapy Market contains market size and forecasts of Tricuspid Valve Interventional Therapy in Global, including the following market information:
- Global Tricuspid Valve Interventional Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Tricuspid Valve Interventional Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Leaflet Clamping Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Tricuspid Valve Interventional Therapy include Edwards Lifesciences, OrbusNeich P&F, Abbott, Medtronic, Peijia Medical and MicroPort CardioFlow Medtech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Tricuspid Valve Interventional Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tricuspid Valve Interventional Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Tricuspid Valve Interventional Therapy Market Segment Percentages, by Type, 2021 (%)
- Leaflet Clamping
- Annulus Retraction
- Increase The Matching Area
Global Tricuspid Valve Interventional Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Tricuspid Valve Interventional Therapy Market Segment Percentages, by Application, 2021 (%)
- Tricuspid Regurgitation
- Decreased Tricuspid Valve Deformity
- Others
Global Tricuspid Valve Interventional Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Tricuspid Valve Interventional Therapy Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Tricuspid Valve Interventional Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Tricuspid Valve Interventional Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Edwards Lifesciences
- OrbusNeich P&F
- Abbott
- Medtronic
- Peijia Medical
- MicroPort CardioFlow Medtech
Industry Market Size
